{"id":"W4411534911","doi":"10.1161/circulationaha.125.074037","title":"Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial","year":2025,"lang":"en","type":"article","venue":"Circulation","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Canadian VIGOUR Centre; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; TIMI; Rivaroxaban; Atrial fibrillation; Internal medicine; Cardiology; Azalea; Myocardial infarction; Warfarin; Percutaneous coronary intervention","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004217099,0.001506901,0.003123335,0.0003884579,0.0003021236,0.001633573,0.0007375386,0.001133202,0.003914251],"category_scores_gemma":[0.005525268,0.000412975,0.005797857,0.0006399308,0.0003673212,0.0008020595,0.0005524249,0.00192927,0.0004738965],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005806042,"about_ca_system_score_gemma":0.001002656,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004311124,"about_ca_topic_score_gemma":0.001665585,"domain_scores_codex":[0.9963419,0.002133377,0.0003277345,0.0005227531,0.0003826308,0.0002916221],"domain_scores_gemma":[0.9964186,0.001517787,0.001109785,0.0003317826,0.0001660126,0.0004559818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9220772,0.001152445,0.02464224,0.001464947,0.02901511,0.0002245793,0.00006758403,0.00142282,0.001907679,0.0002662688,0.002357082,0.01540213],"study_design_scores_gemma":[0.7498492,0.04285846,0.159041,0.0002860917,0.03620243,0.0005422668,0.00009360135,0.00443628,0.00102664,0.001186095,0.004360984,0.000116971],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9782241,0.01180856,0.000631025,0.0007467269,0.0002940814,0.001033095,0.003759975,0.00005038578,0.003452093],"genre_scores_gemma":[0.988673,0.002135767,0.0007195756,0.0008132496,0.0005633433,0.0009364875,0.005156535,0.00002037131,0.0009816065],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004217099,"threshold_uncertainty_score":0.02230245,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02120121647370525,"score_gpt":0.2735585766610036,"score_spread":0.2523573601872984,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}